维普期刊资源整合服务平台（V6.5）

441篇 您的检索式：作者名="Wiersinga"

选中清除导出查看参考文献查看引证文献引用追踪共23页首页上一页第1页下一页末页 /23 跳转

	题名	作者	年代	出处	被引量
1	Test-Retest Reliability of the GO-QOL显示文摘	C.B. Terwee M.N. Gerding F.W. Dekker M.F. Prummel J.P. van der Pol W.M. Wiersinga	1999	Journal of Clinical Epidemiology1999，，9：	2
2	Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis显示文摘	Wiersinga WJ Veer CT Wieland CW	2007	J Infect Dis2007，196，11：	1
3	Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active graves' orbitopathy 显示文摘	Bartalena L Krassas GE Wiersinga W	2012	J Clin Endocrinol Metab2012，97，12：	1
4	Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters显示文摘	Gerding MNt Prmmnel MY Wiersinga WM	2000	Clin Endocrinol(Oxf)2000，52，：	1
5	From gene to disease : thyroid stimulating hormone receptor, hyperthyroidism and hypothyroidism显示文摘	WIERSINGA W M	2001	Ned Tijdschr Geneeskd2001，145，18：	1
6	Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?显示文摘	Wiersinga WM	2011	J Clin Endocrinol Metab2011，96，：	1
7	Clinical assessment of patients with Graves orbi topathy , the European Group on Graves' Orbitopat hy recommendations to generalists, specialists and clinical researchers显示文摘	European Group on Graves Orbitopathy (EUGOGO) Wiersinga WM Perros Pv	2006	EurJ Endocrinol2006，155，3：	1
8	Multicenter studyon the characteristics and treatment strategies of patients withGravesf orbitopathy : the first European Group on Gravesr orbitopa-thy experience 显示文摘	Prummel MF Bakker A Wiersinga WM	2003	Eur J Endocrinol2003，148，9：	1
9	The environment and autoimmune thyroid diseases显示文摘	Prummel MF Strieder T Wiersinga WM	2004	Eur J Endocrinol2004，150，5：	1
10	In-itial thyroid status and cardiovascular risk factors : the EPIC-Norfolk prospective population study 显示文摘	BOEKHOLDT S M TITAN S M WIERSINGA WM	2010	Clin Endocrinol(Oxf)2010，72，3：	1
11	Thyroid peroxidase autoantibodies in euthyroid subjects 显示文摘	Prummel MF Wiersinga WM	2005	Best Pract Res Clin Endocrinol Metab2005，19，1：	1
12	Clinicalactivity score as a guide in the management of patientswith Graves’ ophthalmopathy 显示文摘	Mounts MP Prummel MF Wiersinga WM	1997	Clin Endocrinol1997，47，1：	1
13	The systemic pro-inflammatory response in sepsis显示文摘	de Jong HK van der Poll T Wiersinga WJ	2010	J Innate Immun2010，2，5：	1
14	Mana- genent of the nontoxic multonodular goiter a European questionnaire study显示文摘	Bonnema SJ Bennedaek FN Wiersinga WN	2000	Clin Endocrinol (Oxf)2000，53，1：	1
15	Thyroid peroxidase autoantibodies in euthyroid subjects显示文摘	Prummel M F Wiersinga W M	2005	Best Pract Res Clin Endocrinol Metab2005，19，1：	1
16	Clinical presentation of Graves ' ophthalmopathy 显示文摘	WIERSINGA W M SMIT T VAN DER GAAG R	1989	Ophthalmic Res1989，21，2：	1
17	Childhood Graves' oph- thalmopathy: esults of a European questionnaire study显示文摘	Krassas GE Segni M Wiersinga WM	2005	Eur J Endocrinol2005，153，4：	1
18	Inflammation, endothelium, and coagulation in sepsis 显示文摘	Schouten M Wiersinga WJ Levi M	2008	J Leukoc Biol2008，83，3：	1
19	Preventing Graves' ophthalmopathy 显示文摘	Wiersinga WM	1998	N Engl J Med1998，338，2：	1
20	Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death显示文摘	Benhadi N Wiersinga WM Reitsma JB	2009	Eur J Endocrinol2009，160，6：	1

返回顶部每页显示：

共23页首页上一页第1页下一页末页 /23 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示